Brian Grow serves as the Chief Commercial Officer at Organogenesis Holdings Inc Class A, a leading regenerative medicine company focused on the development, manufacture, and commercialization of advanced wound care and surgical biologic products. In his role, Brian is responsible for overseeing the company's commercial strategy and operations, driving growth and expanding market presence in the regenerative medicine sector. With an extensive background in the life sciences industry, Brian brings a wealth of experience and expertise to his position at Organogenesis. Prior to joining the company, he held various leadership roles at prominent healthcare organizations, where he successfully led sales teams, developed and executed strategic initiatives, and fostered key partnerships to drive business growth. Brian's strong track record of achievement in the industry has been instrumental in positioning Organogenesis for continued success and innovation in the regenerative medicine market. As Chief Commercial Officer, Brian plays a crucial role in shaping the future of Organogenesis and its mission to improve patient outcomes through advanced regenerative therapies. His strategic vision, coupled with his deep understanding of the healthcare landscape, enables him to effectively guide the company's commercial efforts and capitalize on emerging opportunities in the rapidly evolving field of regenerative medicine. Under Brian's leadership, Organogenesis is well-positioned to continue delivering innovative solutions that address unmet medical needs and enhance the quality of life for patients worldwide.